Author: Tan, Zhaoli; Gao, Lihua; Wang, Yan; Yin, Huihui; Xi, Yongyi; Wu, Xiaojie; Shao, Yong; Qiu, Weiyi; Du, Peng; Shen, Wenlong; Fu, Ling; Jia, Ru; Zhao, Chuanhua; Zhang, Yun; Zhao, Zhihu; Sun, Zhiwei; Chen, Hongxing; Hu, Xianwen; Xu, Jianming; Wang, Youliang
Title: PRSS contributes to cetuximab resistance in colorectal cancer Document date: 2020_1_1
ID: tymoeyoo_28
Snippet: SPINK1 combined with cetuximab or bevacizumab treatment inhibits colon cancer cell growth in xenograft models.....
Document: SPINK1 combined with cetuximab or bevacizumab treatment inhibits colon cancer cell growth in xenograft models
Search related documents:
Co phrase search for related documents- bevacizumab treatment cetuximab and cell growth: 1
- cancer xenograft model cell growth and cell growth: 1
- cancer xenograft model cell growth and xenograft model: 1
- cancer xenograft model cell growth and xenograft model cell growth: 1
- cell growth and xenograft model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell growth and xenograft model cell growth: 1, 2
Co phrase search for related documents, hyperlinks ordered by date